Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction
AT1R-AAs and ETAR-AAs are associated with an increased risk of MACE after STEMI. Assessment of autoantibody levels paves the way for future therapies targeting specific molecular pathways associated with poor prognosis after an acute coronary event.
Authors
- Francesco Tona (ORCID: https://orcid.org/0000-0003-4828-7875)
- Martina Perazzolo Marra (ORCID: https://orcid.org/0000-0001-7645-6993)
- Emanuele Cozzi (ORCID: https://orcid.org/0000-0001-7855-5055)
- Giovanni Civieri (ORCID: https://orcid.org/0000-0002-3076-4787)
- Sabino Iliceto (ORCID: https://orcid.org/0000-0002-3676-8746)
- Marta Vadori (ORCID: https://orcid.org/0000-0002-9763-2383)
- Benedetta Schiavon
- Giacomo Bernava (ORCID: https://orcid.org/0000-0001-8033-6409)
- Giulia Masiero (ORCID: https://orcid.org/0000-0003-4209-6824)
- Loira Leoni (ORCID: https://orcid.org/0000-0002-9037-2320)
- Donatella Tansella (ORCID: https://orcid.org/0009-0005-9684-6426)
- Laura Iop (ORCID: https://orcid.org/0000-0002-7034-9414)
- Annagrazia Cecere (ORCID: https://orcid.org/0000-0001-5587-1215)
- Marika Martini (ORCID: https://orcid.org/0009-0000-0522-8408)
Institutions
- University of Padua (IT)
- LUM Jean Monnet University (IT)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fcvm.2025.1515693
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00